Evoq Remedies touches roof on receiving export order of Rs 136 crore
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
EVOQ Remedies is currently trading at upper limit of Rs. 16.20, up by 2.70 points or 20.00% from its previous closing of Rs. 13.50 on the BSE.
The scrip opened at Rs. 14.70 and has touched a high and low of Rs. 16.20 and Rs. 14.70 respectively. So far 2124000 shares were traded on the counter.
The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 18.49 on 19-Jun-2023 and a 52 week low of Rs. 10.50 on 16-Oct-2023.
Last one week high and low of the scrip stood at Rs. 16.20 and Rs. 13.37 respectively. The current market cap of the company is Rs. 22.03 crore.
The promoters holding in the company stood at 73.53%, while Non-Institutions held 26.47% stake in the company.
Evoq Remedies has received Export order of Rs 136 crore from the Marlexx Pharma Inc. to deliver high-quality pharmaceutical products and marks a significant step forward in its business growth. The order includes a range of pharmaceutical APIs namely Metformin API, Tramadol Hydrochloride API, Lisinopril API Powder, Omeprazole Powder API, Cefoxitin Sodium Sterile, Colistimethate Sodium Sterile, Meropenem Sterile and Pipracillin Sodium Sterile.
Evoq Remedies is one of the recognized trading house of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs at affordable price catering to the customers located in Ahmedabad.
